General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: National Institutes of Health (USA)(MODEST), Eli Lilly and Company(MODEST) OTHER FINANCIAL BENEFIT: Genentech Inc(MODEST), Sanofi Aventis(SIGNIFICANT), Sanofi-Aventis Australia Pty Ltd(SIGNIFICANT), Esperion Therapeutics Inc.(SIGNIFICANT), American Regent(SIGNIFICANT), DalCor Pharma UK Inc.(SIGNIFICANT), CSL Behring LLC(SIGNIFICANT), Janssen Pharmaceuticals, Inc(SIGNIFICANT)

View Full Disclosure